Growth Metrics

Soleno Therapeutics (SLNO) Return on Capital Employed (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Return on Capital Employed for 8 consecutive years, with 0.02% as the latest value for Q4 2025.

  • For Q4 2025, Return on Capital Employed changed N/A year-over-year to 0.02%; the TTM value through Dec 2025 reached 0.02%, changed N/A, while the annual FY2019 figure was 0.66%, 29.0% down from the prior year.
  • Return on Capital Employed hit 0.02% in Q4 2025 for Soleno Therapeutics, up from 0.09% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.02% in Q4 2025 and bottomed at 0.41% in Q1 2025.